Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease - a Prospective Nationwide Multicentre Study

NCT05322057 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05322057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease - a Prospective Nationwide Multicentre Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
December 1, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, fistula perianal